Surveillance of pediatric parapneumonic effusion/empyema in New Zealand.
Katherine Rix-TrottCatherine Ann ByrnesCatherine A GilchristRichard MatsasTony WallsLesley VossCaroline MahonNigel P DicksonPeter ReedEmma J BestPublished in: Pediatric pulmonology (2021)
New Zealand has a high incidence of pediatric complicated parapneumonic effusion/empyema with significant morbidity. S. aureus was a significant cause of severe empyema in New Zealand, particularly for Māori and Pasifika children. Improvements in vaccine coverage are needed along with strategies to reduce S. aureus disease morbidity.